Pharmacokinetics and Safety of KRN7000 Following Intravenous Infusion of RGI-2001 in Allogeneic Transplant Patients

被引：0
|
作者：
Chen, Yi-Bin
Lee, Dana D.
Lane, Hayley
Smith, Steve
Ishii, Yasuyuki
Lekakis, Lazaros J.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-141526
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Pharmacokinetics, Safety and Tolerability of Foslevodopa/Foscarbidopa Following Continuous Subcutaneous Infusion to Arm, Thigh and Flank Compared to Abdomen in Parkinson's Disease Patients
    Han, Y.
    Kalluri, H.
    Jeong, A.
    Locke, C.
    Facheris, M.
    Gupta, S.
    Rosebraugh, M.
    MOVEMENT DISORDERS, 2023, 38 : S27 - S27
  • [42] Safety, Tolerability and Pharmacokinetics of MCI-186 in Patients with Acute Ischemic Stroke: a New Dose Regimen of Bolus plus 72-Hour Intravenous Infusion
    Kaste, M.
    Murayama, S.
    Tatlisumak, T.
    Ford, G.
    Koudstaal, P. J.
    Walters, M.
    CEREBROVASCULAR DISEASES, 2013, 35 : 298 - 298
  • [43] PHARMACOKINETICS OF CHLOROQUINE IN THAIS - PLASMA AND RED-CELL CONCENTRATIONS FOLLOWING AN INTRAVENOUS-INFUSION TO HEALTHY-SUBJECTS AND PATIENTS WITH PLASMODIUM-VIVAX MALARIA
    EDWARDS, G
    LOOAREESUWAN, S
    DAVIES, AJ
    WATTANAGOON, Y
    PHILLIPS, RE
    WARRELL, DA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (04) : 477 - 485
  • [44] PHARMACOKINETICS OF IFOSFAMIDE AND ITS ENANTIOMERS FOLLOWING A SINGLE 1-H INTRAVENOUS-INFUSION OF THE RACEMATE IN PATIENTS WITH SMALL-CELL LUNG-CARCINOMA
    CORLETT, SA
    PARKER, D
    CHRYSTYN, H
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (04) : 452 - 455
  • [45] SAFETY AND EFFICACY OF BRENTUXIMAB VEDOTIN (SGN-35) IN HODGKIN LYMPHOMA PATIENTS UNDERGOING REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANT FOLLOWING A RELAPSE AFTER AUTOLOGOUS TRANSPLANT
    Zallio, F.
    Busca, A.
    Mordini, N.
    Ferrando, F.
    Bruno, B.
    Salvi, F.
    Levis, A.
    Pini, M.
    HAEMATOLOGICA, 2014, 99 : 431 - 432
  • [46] Safety and Efficacy of Brentuximab Vedotin (SGN-35) in Hodgkin Lymphoma Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplant Following a Relapse After Autologous Transplant
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (08) : 20 - 20
  • [47] SAFETY AND EFFECTIVENESS OF INTRAVENOUS PENTAMIDINE AS A FIRST LINE PNEUMOCYSTIS JIROVECI PNEUMONIA (PJP) PROPHYLAXIS IN PEDIATRIC PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC PROGENITOR CELL TRANSPLANT (AHPCT)
    Drillon, M. A.
    Chaleff, S.
    Duerst, R.
    Klein-Gitelman, M.
    Kletzel, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S264 - S264
  • [48] AN OPEN STUDY TO ASSESS THE SAFETY, TOLERANCE AND PHARMACOKINETICS OF AN INTRAVENOUS-INFUSION OF GRANISETRON GIVEN AT 3 MG OVER 30 S IN PATIENTS RECEIVING CHEMOTHERAPY FOR MALIGNANT DISEASE
    CARMICHAEL, J
    PHILIP, PA
    FORFAR, C
    HARRIS, AL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 37 (1-2) : 134 - 138
  • [49] A phase I study of the safety and pharmacokinetics (PK) of XMT-1001 given as an intravenous (IV) infusion once every three weeks to patients with advanced solid tumors
    Sausville, E.
    Garbo, L.
    Weiss, G. J.
    Anthony, S.
    Shkolny, D.
    Yurkovetskiy, A. V.
    Bethune, C.
    Fram, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] Safety, tolerability, pharmacokinetics and pharmacodynamic activity of terlipressin delivered by continuous intravenous infusion in patients with cirrhosis and refractory ascites: a phase 2a open-label trial
    Bajaj, Jasmohan
    Yeramian, Patrick
    Gavis, Edith
    Fagan, Andrew
    Fischer, James
    Garcia-Tsao, Guadalupe
    Angeli, Paolo
    Smith, Denise
    Adams, Jonathan
    Markham, Penelope
    JOURNAL OF HEPATOLOGY, 2020, 73 : S718 - S719
12345